NCT01190475View on ClinicalTrials.gov

BGS649 Monotherapy in Moderate to Severe Endometriosis Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Endometriosis
Interventions
DRUG

Active treatment with a high dose of BGS649

DRUG

Active treatment with a low dose of BGS649

DRUG

Placebo treatment to blind study

Trial Locations (1)

92801

Novartis Investigative Site, Anaheim

Sponsors

Lead Sponsor

Mereo BioPharma

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Mereo BioPharma

INDUSTRY